Storage and handling
Tamper resistant for your protection. Use only if safety seal is intact
Tamper resistant for your protection. Use only if safety seal is intact
Reduces aggressive behavior
Drug Facts
Active Ingredients: Each dose contains equal parts of: Arsenicum alb 30C HPUS, Belladonna 30C HPUS, Chamomilla 3X HPUS, Hepar sulph calc 30C HPUS, Scutellaria 3X HPUS
Uses: Homeopathic calming remedy for aggressive animals
Warnings: If symptoms persist or worsen, seek advice of a veterinarian
If pet is pregnant or nursing, give only on advice of a veterinarian
Keep this and all medications out of reach of children
Directions: Initially, depress pump until primed. Hold close to pet's mouth and spray directly, or spray onto its food or water. Use 3 times daily. Cats and dogs under 20 lbs: 2 sprays. Dogs 20-50 lbs: 3 sprays. Dogs over 50 lbs: 4 sprays.
Inactive Ingredients: Citric acid, potassium sorbate, purified water
The letters HPUS indicate that the components in this product are officially monographed in the Homeopathic Pharmacopoeia of the United States.
All Native Remedies health products are especially formulated by experts in the field of natural health and are manufactured according to the highest pharmaceutical standards for maximum safety and effectiveness. For more information, visit us at
www.petalive.com
Distributed by
Native Remedies, LLC
6531 Park of Commerce Blvd.
Suite 160
Boca Raton, FL 33487
Phone: 1.877.289.1235
International: +1.561.999.8857
Contains no artificial flavors or artificial colors. No gluten added
Tamper resistant for your protection. Use only if safety seal is intact
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ARSENIC TRIOXIDE | ACTIVE INGREDIENT | S7V92P67HO | 2 | |
| ATROPA BELLADONNA | ACTIVE INGREDIENT | WQZ3G9PF0H | 2 | |
| CALCIUM SULFIDE | ACTIVE INGREDIENT | 1MBW07J51Q | 2 | |
| MATRICARIA RECUTITA | ACTIVE INGREDIENT | G0R4UBI2ZZ | 2 | |
| SCUTELLARIA LATERIFLORA | ACTIVE INGREDIENT | 7BP4DH5PDC | 2 | |
| ARSENIC CATION (3+) | ACTIVE MOIETY | C96613F5AV | 2 | |
| ATROPA BELLADONNA | ACTIVE MOIETY | WQZ3G9PF0H | 2 | |
| CALCIUM SULFIDE | ACTIVE MOIETY | 1MBW07J51Q | 2 | |
| MATRICARIA RECUTITA | ACTIVE MOIETY | G0R4UBI2ZZ | 2 | |
| SCUTELLARIA LATERIFLORA | ACTIVE MOIETY | 7BP4DH5PDC | 2 | |
| CITRIC ACID MONOHYDRATE | INACTIVE INGREDIENT | 2968PHW8QP | 2 | |
| POTASSIUM SORBATE | INACTIVE INGREDIENT | 1VPU26JZZ4 | 2 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 68703-130 | 68703-130-59 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ARSENIC TRIOXIDE | S7V92P67HO | ACTIB |
| ATROPA BELLADONNA | WQZ3G9PF0H | ACTIB |
| MATRICARIA RECUTITA | G0R4UBI2ZZ | ACTIB |
| CALCIUM SULFIDE | 1MBW07J51Q | ACTIB |
| SCUTELLARIA LATERIFLORA | 7BP4DH5PDC | ACTIB |
| CITRIC ACID MONOHYDRATE | 2968PHW8QP | IACT |
| POTASSIUM SORBATE | 1VPU26JZZ4 | IACT |
| WATER | 059QF0KO0R | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | POWDER, FOR SUSPENSION / ORAL | 840 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TROCHE / ORAL | 12 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | LIQUID / ORAL | 114 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | EMULSION / TOPICAL | 0.11 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, EFFERVESCENT / ORAL | 460 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | ELIXIR / ORAL | 100 mg/5ml | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | LOTION / TOPICAL | 0.2 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SPRAY / NASAL | 9 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SUSPENSION/ DROPS / ORAL | 19 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | CREAM / VAGINAL | 0.49 %w/w | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 0.2 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | NA | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | CAPSULE, EXTENDED RELEASE / ORAL | 101 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | OINTMENT / TOPICAL | 1 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SUSPENSION / ORAL | 269 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, EXTENDED RELEASE / ORAL | 45 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INFILTRATION | 0.02 %w/v | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | CREAM / TOPICAL | 0.25 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRAPLEURAL | ADJ PH | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SUSPENSION / ORAL | 400 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | EMULSION / OPHTHALMIC | 0.47 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / BUCCAL | NA | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | CREAM / TOPICAL | 4 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | AEROSOL, FOAM / TOPICAL | 8 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | AEROSOL, FOAM / TOPICAL | 1 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | PASTE / ORAL | 48 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 2 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SYRUP / ORAL | 722 mg/5ml | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRABURSAL | ADJ PH | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, ORALLY DISINTEGRATING / ORAL | 83 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, FILM COATED / ORAL | 42 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 38 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRATHECAL | ADJ PH | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | CAPSULE / ORAL | NA | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | TABLET, EXTENDED RELEASE / ORAL | 0.2 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SUSPENSION / OPHTHALMIC | ADJ PH | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION, CONCENTRATE / IRRIGATION | 1 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRALESIONAL | ADJ PH | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, CHEWABLE / ORAL | 7 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SHAMPOO / TOPICAL | 17 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, COATED / ORAL | NA | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / AURICULAR (OTIC) | 0.2 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / INTRAMUSCULAR | 0.05 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION/ DROPS / OPHTHALMIC | 0.05 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRAVENOUS | 2068 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRASYNOVIAL | ADJ PH | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION / INTRAMUSCULAR | 26 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / PERIDURAL | NA | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / ORAL | 446 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SUSPENSION / RESPIRATORY (INHALATION) | 0.03 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / INTRAVENOUS | 10 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | TABLET / ORAL | 6 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SOLUTION/ DROPS / OPHTHALMIC | 0.47 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | POWDER, FOR SOLUTION / TOPICAL | NA | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | FILM, EXTENDED RELEASE / TRANSDERMAL | 1.38 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | DROPS / ORAL | NA | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRAMUSCULAR | 28 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | DOUCHE / VAGINAL | 0.07 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / INTRAOCULAR | 1 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SUSPENSION, EXTENDED RELEASE / ORAL | 140.8 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Arsenic Trioxide | ARSENIC TRIOXIDE | Heritage Pharma Labs Inc. d/b/a Avet Pharmaceuticals Inc | 8dddfe9e-06bf-4983-9c55-71b19da8fcdc | 2025-11-07 | Boxed warning, Warnings, Adverse reactions | ARSENIC TRIOXIDE |
| Arsenic Trioxide | ARSENIC TRIOXIDE | Fresenius Kabi USA, LLC | a482eccd-8837-47ea-904d-2f2c294d10fa | 2025-08-21 | Boxed warning, Warnings, Adverse reactions | ARSENIC TRIOXIDE |
| ARSENIC TRIOXIDE | ARSENIC TRIOXIDE | Eugia US LLC | 2a999752-f350-4eff-97e7-e7106dfa85b5 | 2025-06-30 | Boxed warning, Warnings, Adverse reactions | ARSENIC TRIOXIDE |
| Arsenic trioxide | ARSENIC TRIOXIDE | Zydus Pharmaceuticals USA Inc. | 3e1d2b63-ccb2-4e97-a009-5983eabf65e4 | 2025-05-14 | Boxed warning, Warnings, Adverse reactions | ARSENIC TRIOXIDE |
| Arsenic trioxide | ARSENIC TRIOXIDE | Zydus Pharmaceuticals USA Inc. | ae5cae02-ca57-4da5-8940-81253fdb8679 | 2025-05-12 | Boxed warning, Warnings, Adverse reactions | ARSENIC TRIOXIDE |
| ARSENIC TRIOXIDE | ARSENIC TRIOXIDE | Nordic Pharma, Inc. | d1e2107c-26c3-40fc-978e-0ba5b84098ac | 2025-03-20 | Boxed warning, Warnings, Adverse reactions | ARSENIC TRIOXIDE |
| Arsenic Trioxide | ARSENIC TRIOXIDE | Nexus Pharmaceuticals LLC | 2b2a7ed9-5ed3-42fc-b19b-d50700396233 | 2025-03-03 | Boxed warning, Warnings, Adverse reactions | ARSENIC TRIOXIDE |
| Arsenic trioxide | ARSENIC TRIOXIDE | Zydus Pharmaceuticals USA Inc. | e9d27f88-de82-4379-b143-4b94b3dd8bbe | 2025-02-21 | Boxed warning, Warnings, Adverse reactions | ARSENIC TRIOXIDE |
| Arsenic trioxide | ARSENIC TRIOXIDE | Zydus Pharmaceuticals USA Inc. | e1ad5d87-e65e-402f-86b5-e641fc4e61ab | 2025-02-21 | Boxed warning, Warnings, Adverse reactions | ARSENIC TRIOXIDE |
| Arsenicum Album 200ck | ARSENIC TRIOXIDE | SEVENE USA | c8d6dcbf-a5a9-5231-e053-2a95a90a7354 | 2025-02-11 | Warnings | ARSENIC TRIOXIDE |
| ARSENIC TRIOXIDE | ARSENIC TRIOXIDE | Northstar Rx LLC | 48388282-3768-4309-8982-2766cbc9fd59 | 2024-10-07 | Boxed warning, Warnings, Adverse reactions | ARSENIC TRIOXIDE |
| Arsenic Trioxide | ARSENIC TRIOXIDE | Gland Pharma Limited | 2cb52683-1e74-4831-a771-55a78536cfe5 | 2024-09-12 | Boxed warning, Warnings, Adverse reactions | ARSENIC TRIOXIDE |
| ARSENIC TRIOXIDE | ARSENIC TRIOXIDE | Novadoz Pharmaceuticals LLC | 8849c8f9-ee41-4ccd-8a62-67b04e80a276 | 2024-02-06 | Boxed warning, Warnings, Adverse reactions | ARSENIC TRIOXIDE |
| Arsenicum Album 30c | ARSENIC TRIOXIDE | SEVENE USA | 97e7b573-bdc0-4b04-bf24-a24a037cdd19 | 2024-01-23 | Warnings | ARSENIC TRIOXIDE |
| Arsenicum album | ARSENIC TRIOXIDE | Boiron | 84239859-3fc6-24da-e053-2a91aa0a3420 | 2023-12-21 | ARSENIC TRIOXIDE | |
| Arsenicum album | ARSENIC TRIOXIDE | Boiron | 84effad6-a09f-7420-e053-2a91aa0aa55e | 2023-12-21 | ARSENIC TRIOXIDE | |
| Arsenicum album | ARSENIC TRIOXIDE | Boiron | 8423631c-cc03-91a1-e053-2991aa0ac389 | 2023-12-21 | ARSENIC TRIOXIDE | |
| Arsenicum album | ARSENIC TRIOXIDE | Boiron | af651430-79fe-11e6-8a76-424c58303031 | 2023-12-21 | ARSENIC TRIOXIDE | |
| Arsenicum album | ARSENIC TRIOXIDE | Boiron | 84235a97-161a-175f-e053-2991aa0a16cd | 2023-12-21 | ARSENIC TRIOXIDE | |
| ARSENIC TRIOXIDE | ARSENIC TRIOXIDE | Sintetica US LLC | d921f52f-2f38-4300-ae40-31f00b3a500a | 2023-11-15 | Boxed warning, Warnings, Adverse reactions | ARSENIC TRIOXIDE |
Adverse event summaries are temporarily unavailable. Other product information remains available.